{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:49:00Z","timestamp":1791895740077,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","award":["NIHR306249"],"award-info":[{"award-number":["NIHR306249"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.schres.2026.08.010","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:52:19Z","timestamp":1787601139000},"page":"194-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Off-licence use of clozapine: Lessons from an inner-city NHS trust \u2013 Comparison with other NHS Trusts"],"prefix":"10.1016","volume":"297","author":[{"given":"Eromona","family":"Whiskey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebenezer","family":"Oloyede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olubanke","family":"Dzahini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Aziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Leech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinka","family":"Helthuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhi","family":"Shergill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.schres.2026.08.010_bb0005","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1192\/bjp.2024.236","article-title":"Genetic identification of undiagnosed benign ethnic neutropenia in patients receiving clozapine treatment","volume":"227","author":"Aziri","year":"2025","journal-title":"Br. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2026.08.010_bb0010","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1192\/apt.bp.107.004184","article-title":"Off-label prescribing in psychiatric practice","volume":"13","author":"Baldwin","year":"2007","journal-title":"Adv. Psychiatr. Treat."},{"key":"10.1016\/j.schres.2026.08.010_bb0015","doi-asserted-by":"crossref","DOI":"10.1177\/20451253211032053","article-title":"Clozapine discontinuation withdrawal symptoms in schizophrenia","volume":"11","author":"Blackman","year":"2021","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2026.08.010_bb0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/JCP.0000000000000478","article-title":"Clozapine underutilization in the treatment of schizophrenia: how can clozapine prescription rates be improved?","volume":"36","author":"Bogers","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.schres.2026.08.010_bb0025","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2020.51","article-title":"Real-world effectiveness of admissions to a tertiary treatment-resistant psychosis service: 2-year mirror-image study","volume":"6","author":"Casetta","year":"2020","journal-title":"BJPsych Open"},{"key":"10.1016\/j.schres.2026.08.010_bb0030","article-title":"Global trends in clozapine utilisation between 2014 and 2024: a longitudinal epidemiological study with data from 75 countries","volume":"63","author":"Fitzgerald","year":"2026","journal-title":"Lancet Reg. Health Eur."},{"issue":"2","key":"10.1016\/j.schres.2026.08.010_bb0035","first-page":"351","article-title":"Suicide rates among people with serious mental illness: a systematic review and meta-analysis","volume":"53","author":"Fu","year":"2023","journal-title":"Psychol. Med."},{"issue":"2\u20133","key":"10.1016\/j.schres.2026.08.010_bb0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.schres.2004.05.015","article-title":"Suicidal risk during treatment with clozapine: a meta-analysis","volume":"73","author":"Hennen","year":"2005","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.schres.2026.08.010_bb0045","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/bloodadvances.2024014399","article-title":"Characterization of the phenotypic consequences of the Duffy-null genotype","volume":"9","author":"Hysong","year":"2025","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.schres.2026.08.010_bb0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1192\/bja.2021.61","article-title":"Adults with Parkinson's disease and hallucinations or delusions can have treatment with clozapine if they need to","volume":"28","author":"Joyce","year":"2022","journal-title":"BJPsych Adv."},{"issue":"8","key":"10.1016\/j.schres.2026.08.010_bb0055","first-page":"751","article-title":"FDA eliminates the clozapine REMS\u2014what comes next?","volume":"82","author":"Kelly","year":"2025","journal-title":"JAMA Psych."},{"key":"10.1016\/j.schres.2026.08.010_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/ipm.2026.10183","article-title":"Clozapine: revised haematological monitoring recommendations","author":"Lally","year":"2026","journal-title":"Ir. J. Psychol. Med."},{"issue":"4","key":"10.1016\/j.schres.2026.08.010_bb0065","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/acps.12700","article-title":"The impact of clozapine on hospital use: a systematic review and meta-analysis","volume":"135","author":"Land","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"issue":"11","key":"10.1016\/j.schres.2026.08.010_bb0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1192\/pb.24.11.415","article-title":"Off-label prescribing by psychiatrists","volume":"24","author":"Lowe-Ponsford","year":"2000","journal-title":"Psychiatr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2026.08.010_bb0075","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1192\/bjp.2019.267","article-title":"In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine","volume":"217","author":"Luykx","year":"2020","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.08.010_bb0080","article-title":"A systematic review of personality disorder, race and ethnicity: prevalence, aetiology and treatment","volume":"10","author":"McGilloway","year":"2010","journal-title":"BMC Psych."},{"issue":"1","key":"10.1016\/j.schres.2026.08.010_bb0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpsyc.60.1.82","article-title":"Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT)","volume":"60","author":"Meltzer","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2026.08.010_bb0090","series-title":"NICE Guideline NG71","article-title":"Parkinson\u2019s disease in adults","author":"National Institute for Health and Care Excellence","year":"2017"},{"issue":"1","key":"10.1016\/j.schres.2026.08.010_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S2215-0366(23)00343-7","article-title":"Evaluating the epidemiology of clozapine-associated neutropenia among people on clozapine across Australia and Aotearoa New Zealand: a retrospective cohort study","volume":"11","author":"Northwood","year":"2024","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.08.010_bb0100","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s12888-021-03514-6","article-title":"Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitals","volume":"21","author":"Oloyede","year":"2021","journal-title":"BMC Psych."},{"key":"10.1016\/j.schres.2026.08.010_bb0105","doi-asserted-by":"crossref","DOI":"10.1017\/S204579602200066X","article-title":"Clozapine haematological monitoring for neutropenia: a global perspective","volume":"31","author":"Oloyede","year":"2022","journal-title":"Epidemiol. Psychiatr. Sci."},{"issue":"8","key":"10.1016\/j.schres.2026.08.010_bb0110","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S2215-0366(22)00188-2","article-title":"Relaxation of the criteria for entry to the UK clozapine central non-rechallenge database: a modelling study","volume":"9","author":"Oloyede","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2026.08.010_bb0115","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.2023.44","article-title":"Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study","volume":"223","author":"Oloyede","year":"2023","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.08.010_bb0120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41537-023-00353-0","article-title":"What are the barriers and facilitators of clozapine use in early psychosis? A survey of UK early intervention clinicians","volume":"9","author":"Oloyede","year":"2023","journal-title":"Schizophrenia"},{"issue":"6","key":"10.1016\/j.schres.2026.08.010_bb0125","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/acps.13621","article-title":"Clozapine augmentation with long-acting antipsychotic injections: a case series and systematic review","volume":"148","author":"Oloyede","year":"2023","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2026.08.010_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/S2215-0366(26)00061-1","article-title":"Clozapine rechallenge after neutropenia: a retrospective cohort study in the UK","author":"Oloyede","year":"2026","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.08.010_bb0135","doi-asserted-by":"crossref","DOI":"10.1017\/neu.2025.10024","article-title":"Competence and confidence of health care professionals in using clozapine: a qualitative systematic review and thematic synthesis","volume":"37","author":"Secchi","year":"2025","journal-title":"Acta Neuropsych."},{"issue":"1","key":"10.1016\/j.schres.2026.08.010_bb0140","article-title":"Clozapine rechallenge and initiation despite neutropenia-a practical, step-by-step guide","volume":"20","author":"Silva","year":"2020","journal-title":"BMC Psych."},{"issue":"3","key":"10.1016\/j.schres.2026.08.010_bb0145","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1503\/jpn.200061","article-title":"Consensus statement on the use of clozapine during the COVID-19 pandemic","volume":"45","author":"Siskind","year":"2020","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.schres.2026.08.010_bb0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.schres.2017.01.036","article-title":"Clozapine and long-acting injectable antipsychotic combination: a retrospective one-year mirror-image study","volume":"188","author":"Souaiby","year":"2017","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.schres.2026.08.010_bb0155","doi-asserted-by":"crossref","first-page":"e933","DOI":"10.4088\/JCP.16m11152","article-title":"Evaluating the effect of the changes in FDA guidelines for clozapine monitoring","volume":"78","author":"Sultan","year":"2017","journal-title":"J. Clin. Psych."},{"issue":"3","key":"10.1016\/j.schres.2026.08.010_bb0160","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/acps.13818","article-title":"The safety of 12-weekly monitoring of neutrophil count in long-term clozapine patients","volume":"152","author":"Taylor","year":"2025","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.schres.2026.08.010_bb0165","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2024.1816","article-title":"The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force","volume":"68","author":"Verdoux","year":"2025","journal-title":"Eur. Psych."},{"issue":"1","key":"10.1016\/j.schres.2026.08.010_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-021-01613-2","article-title":"Efficacy and safety of clozapine in psychotic disorders\u2014a systematic quantitative meta-review","volume":"11","author":"Wagner","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2026.08.010_bb0175","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/acps.13280","article-title":"An evaluation of the variation and underuse of clozapine in the United Kingdom","volume":"143","author":"Whiskey","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"issue":"4","key":"10.1016\/j.schres.2026.08.010_bb0180","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s44220-025-00411-9","article-title":"The paradox of clozapine in Black people with treatment-resistant schizophrenia","volume":"3","author":"Whiskey","year":"2025","journal-title":"Nat. Ment. Health"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426002616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426002616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:04:00Z","timestamp":1791893040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426002616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":36,"alternative-id":["S0920996426002616"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.08.010","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Off-licence use of clozapine: Lessons from an inner-city NHS trust \u2013 Comparison with other NHS Trusts","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}